Kanagawa, Japan

Yoshihiro Sekino

USPTO Granted Patents = 7 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Fujisawa-shi, Kanagawa JP (2001)
  • Fujisawa, JP (2014)
  • Kanagawa, JP (1988 - 2016)

Company Filing History:


Years Active: 1988-2016

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Work of Yoshihiro Sekino in Dementia and Cancer Research

Introduction

Yoshihiro Sekino is a distinguished inventor based in Kanagawa, Japan, known for his significant contributions to the fields of dementia and cancer treatment. With a total of seven patents to his name, Sekino's work continues to impact medical research and development.

Latest Patents

His latest innovations include a therapeutic agent for dementia, which provides a promising pharmaceutically active substance derived from natural sources. Additionally, he has developed an anticancer composition that utilizes extracts from the flowery portion of the elm tree and the leaf portion of the varnish tree, which demonstrate both safety and high efficacy against cancer.

Career Highlights

Throughout his career, Sekino has been associated with renowned companies such as Kibun Company Limited, where he has leveraged his expertise to further medical research and innovation. His numerous patents reflect his commitment to finding viable solutions for some of today's most pressing health issues.

Collaborations

Sekino has also collaborated with notable professionals in his field, including Sachio Wakayama and Toshiko Kadono. These partnerships have allowed him to enhance his research and development efforts, leading to groundbreaking advancements in his projects.

Conclusion

Yoshihiro Sekino stands out as a prolific inventor whose work in dementia and cancer therapeutics holds great potential for future medical advancements. His contributions through innovative patents not only pave the way for new treatments but also inspire ongoing research in these vital areas of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…